4//SEC Filing
LUNDAHL SCOTT L 4
Accession 0001209191-12-018870
CIK 0000879993other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 10:45 AM ET
Size
14.8 KB
Accession
0001209191-12-018870
Insider Transaction Report
Form 4
LUNDAHL SCOTT L
VP, Regulatory Affairs & IP
Transactions
- Sale
Common Stock
2012-03-16$5.75/sh−7,976$45,862→ 220,610 total - Sale
Common Stock
2012-03-16$5.84/sh−1,600$9,344→ 211,086 total - Sale
Common Stock
2012-03-16$5.80/sh−5,224$30,299→ 213,486 total - Sale
Common Stock
2012-03-16$5.81/sh−800$4,648→ 212,686 total - Exercise/Conversion
Non-Qualified Stock Option
2012-03-16−17,500→ 0 totalExercise: $1.60From: 2007-03-13Exp: 2013-03-13→ common stock (17,500 underlying) - Sale
Common Stock
2012-03-16$5.76/sh−1,900$10,944→ 218,710 total - Exercise/Conversion
Common Stock
2012-03-16$1.60/sh+17,500$28,000→ 228,586 total
Footnotes (1)
- [F1]Includes Stock Awards which vest at the rate of one-quarter of the total grant on each of the first, second, third and fourth anniversaries of the date of the grant.
Documents
Issuer
DUSA PHARMACEUTICALS INC
CIK 0000879993
Entity typeother
Related Parties
1- filerCIK 0001205850
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 10:45 AM ET
- Size
- 14.8 KB